Skip to main content

BMT Symposium

The Advances in Blood and Marrow Transplantation 2020 Symposium has been postponed. Please check back for the rescheduled date.

The Advances in Blood and Marrow Transplantation (BMT) Symposium is an annual conference sponsored by The University of Kansas Cancer Center Blood and Marrow Transplant Program, National Marrow Donor Program "Be the Match", and the University of Kansas Medical Center's Area Health Education Center. The conference offers a review of the latest advances in the field of autologous and allogeneic transplantation including, current state-of-the-art treatment strategies, clinical trials research and outcomes of both autologous and allogeneic (related and unrelated donor) transplants to aid in your clinical decision making.

The Advances in Blood and Marrow Transplantation 2020 Symposium 

 

2020 Featured Speakers

Nationally renowned guest speakers

Areej El-Jawahri, M.D.

Director, Blood and Marrow Transplant Survivorship Program, Massachusetts General Hospital

Everett Meyer, M.D., Ph.D.

Medical and Scientific Director, Cellular Therapy Facility, Stanford Health Care Assistant Professor of Medicine, Blood and Marrow Transplantation, Stanford University

Loretta J. Nastoupil, M.D.

Associate Professor Lead, New Drug Development Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center

Miguel-Angel Perales, M.D.

Deputy Chief, Adult Bone Marrow Transplantation Service Director, Adult Stem Cell Transplantation Fellowship, Memorial Sloan Kettering Cancer Center

 

The University of Kansas Medical Center, School of Medicine Speakers

Al-Ola Abdallah, M.D.

Al-Ola Abdallah, MD, Director, Plasma Cell Disorder Clinic, Division of Hematologic Malignancies and Cellular Therapeutics, Assistant Professor of Internal Medicine 

Joseph McGuirk, DO

Chair, Medical Director, Blood and Marrow Transplantation, Professor of Medicine, Acute Leukemia

Dr. McGuirk is the Medical Director of the Blood and Marrow Transplant Program and the University of Kansas Medical Center. Additionally, he is the Director of the Division of Hematologic Malignancies and Cellular Therapeutics and a Schuette-Speas Professor of Hematology-Oncology at KU Medical Center. Dr. McGuirk earned his DO from the Kansas City University of Medicine and Biosciences in Kansas City Missouri. Since joining KU Medical Center, Dr. McGuirk has been involved in many different clinical and research interests, such as Blood and Marrow Transplantation, Allogeneic Stem Cell Transplantation, Hematological Malignancies, Autoimmune Diseases, and more. Dr. McGuirk has been named one of Ingram's Top Doctors as well as one of Kansas City Magazine's Super Doctors. He is also an Honorary Editorial Board Member of "Blood and Lymphatic Cancer: Targets and Therapy".

Tara Lin, M.D., MSCR

Associate Professor; Director, Acute Leukemia Program Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center

Tara Lin, MD, MSCR, is an Associate Professor in the Division of Hematologic Malignancies & Cellular Therapeutics at the University of Kansas, Kansas City, KS. She is the director of the Acute Leukemia Program and Medical Director of the KU Cancer Center Clinical Trials Office.

Dr. Lin received her medical degree from the Medical College of Virginia/Virginia Commonwealth University and a master's degree in clinical research from Tulane University. She completed a residency in Internal Medicine at the University of Maryland and a fellowship in Medical Oncology at Johns Hopkins. She completed an additional two-year post-doctoral fellowship in leukemia stem cells in the laboratory of Dr. Kathleen Sakamoto at UCLA.

Since 2011, she has been on the faculty at the University of Kansas, with a focus on novel therapeutics in acute leukemia.

 

Additional Presenters

Kathy Gaillard, RN

Unit Coordinator, Stem Cell/Pheresis Lab, The University of Kansas Medical Center

Erin Winters, RN, BSN, BMTCN

Site Development Director, Cellular Therapeutics, The University of Kansas Cancer Center

Last modified: Mar 09, 2020
ID=x26406